Skip to main content
Caplight Logo









Ceretrieve

Ceretrieve

Private
IsraelHealthcare & Life Scienceshttps://www.ceretrieve.com/

Last Round

Seed

Jan 5, 2021

Total Funding Raised

$1.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ceretrieve is a medical device company that develops neurointerventional devices intended to treat ischemic stroke.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

neurothrombectomy deviceaspiration catheterischemic strokefirst pass effectmechanical thrombectomystroke treatmentclot retrievallarge vessel occlusionLVOneurovascular interventionendovascular thrombectomyembolic protectioninterventional neuroradiology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ceretrieve Comparables

Compare Ceretrieve with similar companies based on industry and business-model similarity.

Ceretrieve comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RapidPulse
90%
MIVI Neuroscience
87%
Perfuze
86%

Ceretrieve Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 5, 2021

Key People

Founding team and executive leadership

Maysa Mustafa

CEO

Executive Team

Yuval Zipory

Chief Technology Officer

Executive Team

Ceretrieve Investors

Notable investors and investment history

Ceretrieve investors
InvestorRounds
Israel Innovation AuthoritySeed
The Trendlines GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 287% MoM.

  • Mar 17, 2026

    Grew 31% QoQ, from 13 to 17 employees.

Ceretrieve Filings

Explore SEC and related filing metadata, where available.

Ceretrieve filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ceretrieve's valuation, stock price, and market status.

Is Ceretrieve a public or private company?

Ceretrieve is a private company.

What is the current stock price of Ceretrieve?

Ceretrieve is a private company with no public stock price. No recent secondary market data is available.

How much is Ceretrieve worth (valuation)?

Valuation information for Ceretrieve is not publicly available.

Can I buy Ceretrieve stock?

Ceretrieve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ceretrieve's last funding round?

Funding round information for Ceretrieve is not publicly available.

Who are the main investors in Ceretrieve?

Investor information for Ceretrieve is not publicly disclosed.

Will Ceretrieve IPO soon?

No public IPO plans have been announced for Ceretrieve.

How can I track Ceretrieve secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ceretrieve's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range13
Year Founded2017
Last FundingJan 5, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?